Glutaral (CID 3485) - BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(209)
 
 
Inactive(171)
 
 
Inconclusive(39)
 
 
Unspecified(4)
 
 
Top Targets:
NR LBD PPAR(5)
 
 
 
NR LBD TR(4)
 
 
P53(3)
 
 
 
NR LBD VDR(3)
 
 
NR LBD ROR li..(3)
 
 
 
BioAssay Types:
Confirmatory(168)
 
 
 
 
Literature(75)
 
 
 
 
 
Screening(2)
 
 
BioActivity Types:
Potency(132)
 
 
 
 
SAR
Target summary
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 192    Data Row: 423   Total Pages: 9   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID17388988]
Potency 10Cell Viability - LYMP2-022 [AID987, Type: confirmatory]
View
2
[SID17388988]
Potency 11.9955Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory]
View
3
[SID17388988]
Potency 12.5893Cell Viability - LYMP2-024 [AID988, Type: confirmatory]
View
4
[SID17388988]
Potency 15.1014Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory]
View
5
[SID17388988]
Potency 15.8489Cell Viability - LYMP2-020 [AID986, Type: confirmatory]
View
6
[SID17388988]
Potency 15.8489Cell Viability - LYMP2-015 [AID971, Type: confirmatory]
View
7
[SID17388988]
Potency 15.8489Cell Viability - LYMP2-021 [AID974, Type: confirmatory]
View
8
[SID17388988]
Potency 15.8489Cell Viability - LYMP2-012 [AID982, Type: confirmatory]
View
9
[SID17388988]
Potency 15.8489Cell Viability - LYMP2-001 [AID921, Type: confirmatory]
View
10
[SID17388988]
Potency 19.9526Cell Viability - LYMP2-007 [AID979, Type: confirmatory]
View
11
[SID17388988]
Potency 19.9526Cell Viability - LYMP2-017 [AID972, Type: confirmatory]
View
12
[SID17388988]
Potency 19.9526Cell Viability - LYMP2-011 [AID969, Type: confirmatory]
View
13
[SID17388988]
Potency 19.9526Cell Viability - LYMP2-013 [AID970, Type: confirmatory]
View
14
[SID17388988]
Potency 19.9526Cell Viability - LYMP2-010 [AID981, Type: confirmatory]
View
15
[SID17388988]
Potency 19.9526Cell Viability - LYMP2-018 [AID985, Type: confirmatory]
View
16
[SID17388988]
Potency 25.1189Cell Viability - LYMP2-026 [AID989, Type: confirmatory]
View
17
[SID17388988]
Potency 25.1189Cell Viability - LYMP2-009 [AID968, Type: confirmatory]
View
18
[SID17388988]
Potency 25.1189Cell Viability - LYMP2-019 [AID973, Type: confirmatory]
View
19
[SID17388988]
Potency 25.1189Cell Viability - LYMP2-023 [AID975, Type: confirmatory]
View
20
[SID17388988]
Potency 25.1189Cell Viability - LYMP2-008 [AID980, Type: confirmatory]
View
21
[SID17388988]
Potency 25.1189Cell Viability - LYMP2-006 [AID978, Type: confirmatory]
View
22
[SID17388988]
Potency 25.1189Cell Viability - LYMP2-016 [AID984, Type: confirmatory]
View
23
[SID17388988]
Potency 25.1189Cell Viability - LYMP2-014 [AID983, Type: confirmatory]
View
24
[SID17388988]
Potency 25.1189Cell Viability - LYMP2-004 [AID966, Type: confirmatory]
View
25
[SID17388988]
Potency 31.6228Cell Viability - LYMP2-002 [AID977, Type: confirmatory]
View
26
[SID17388988]
Potency 35.4813qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory]Cellular tumor antigen p53 [gi:269849759]
View
27
[SID17388988]
Potency 35.4813qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory]Cellular tumor antigen p53 [gi:269849759]
View
28
[SID17388988]
Potency 35.4813qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory]Cellular tumor antigen p53 [gi:269849759]
View
29
[SID17388988]
Potency 35.4813qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory]Cellular tumor antigen p53 [gi:269849759]
View
30
[SID17388988]
Potency 39.8107Cell Viability - LYMP2-025 [AID976, Type: confirmatory]
View
31
[SID17388988]
Potency 39.8107Cell Viability - LYMP2-003 [AID965, Type: confirmatory]
View
32
[SID17388988]
Potency 50.1187MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells [AID961, Type: confirmatory]
View
33
[SID17388988]
 Cell Viability - Jurkat [AID426, Type: confirmatory]
View
34
[SID17388988]
 Cellular Toxicity (caspase-3) Jurkat [AID655, Type: confirmatory]
View
35
[SID17388988]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_1, Type: other]
View
36
[SID17388988]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_2, Type: other]
View
37
[SID17388988]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_3, Type: other]
View
38
[SID17388988]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_4, Type: other]
View
39
[SID17388988]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_5, Type: other]
View
40
[SID17388988]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_6, Type: other]
View
41
[SID17388988]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_7, Type: other]
View
42
[SID17388988]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_8, Type: other]
View
43
[SID17388988]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_9, Type: other]
View
44
[SID17388988]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_10, Type: other]
View
45
[SID17388988]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_11, Type: other]
View
46
[SID17388988]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_12, Type: other]
View
47
[SID17388988]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_13, Type: other]
View
48
[SID17388988]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_14, Type: other]
View
49
[SID17388988]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_15, Type: other]
View
50
[SID17388988]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_16, Type: other]
View